The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A randomized phase II study of neoadjuvant chemoradiotherapy with 5-FU/leucovorin or irinotecan/S1 in patients with locally advanced rectal cancer.
Minkyu Jung
No relevant relationships to disclose
Sang Joon Shin
No relevant relationships to disclose
Seungtaek Lim
No relevant relationships to disclose
Ji Soo Park
No relevant relationships to disclose
Woong Sub Koom
No relevant relationships to disclose
Ki Chang Keum
No relevant relationships to disclose
Nam Kyu Kim
No relevant relationships to disclose
Seung Hyuk Back
No relevant relationships to disclose
Byung Soh Min
No relevant relationships to disclose
Hyuk Hur
No relevant relationships to disclose
Ho Geun Kim
No relevant relationships to disclose
Jun Seok Lim
No relevant relationships to disclose
Tae IL Kim
No relevant relationships to disclose
Jae Kyung Roh
No relevant relationships to disclose
Young Suk Park
No relevant relationships to disclose
Joong Bae Ahn
No relevant relationships to disclose